Literature DB >> 33515545

The human-specific duplicated α7 gene inhibits the ancestral α7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release.

Carolina Martín-Sánchez1, Eva Alés2, Santiago Balseiro-Gómez2, Gema Atienza1, Francisco Arnalich3, Anna Bordas1, José L Cedillo1, María Extremera1, Arturo Chávez-Reyes4, Carmen Montiel5.   

Abstract

Gene duplication generates new functions and traits, enabling evolution. Human-specific duplicated genes in particular are primary sources of innovation during our evolution although they have very few known functions. Here we examine the brain function of one of these genes (CHRFAM7A) and its product (dupα7 subunit). This gene results from a partial duplication of the ancestral CHRNA7 gene encoding the α7 subunit that forms the homopentameric α7 nicotinic acetylcholine receptor (α7-nAChR). The functions of α7-nAChR in the brain are well defined, including the modulation of synaptic transmission and plasticity underlying normal attention, cognition, learning, and memory processes. However, the role of the dupα7 subunit remains unexplored at the neuronal level. Here, we characterize that role by combining immunoblotting, quantitative RT-PCR and FRET techniques with functional assays of α7-nAChR activity using human neuroblastoma SH-SY5Y cell variants with different dupα7 expression levels. Our findings reveal a physical interaction between dupα7 and α7 subunits in fluorescent protein-tagged dupα7/α7 transfected cells that negatively affects normal α7-nAChR activity. Specifically, in both single cells and cell populations, the [Ca2+]i signal and the exocytotic response induced by selective stimulation of α7-nAChR were either significantly inhibited by stable dupα7 overexpression or augmented after silencing dupα7 gene expression with specific siRNAs. These findings identify a new role for the dupα7 subunit as a negative regulator of α7-nAChR-mediated control of exocytotic neurotransmitter release. If this effect is excessive, it would result in an impaired synaptic transmission that could underlie the neurocognitive and neuropsychiatric disorders associated with α7-nAChR dysfunction.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHRFAM7A; calcium intracellular release; central nervous system; dupα7 nicotinic subunit; human genetics; human-specific duplicate genes; neurotransmitter release; α7 nicotinic acetylcholine receptors

Year:  2021        PMID: 33515545      PMCID: PMC7949125          DOI: 10.1016/j.jbc.2021.100341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  CHRFAM7A expression in mice increases resiliency after injury.

Authors:  Todd W Costantini; Raul Coimbra; Jessica L Weaver; Brian P Eliceiri
Journal:  Inflamm Res       Date:  2021-11-18       Impact factor: 4.575

2.  LiCl attenuates impaired learning and memory of APP/PS1 mice, which in mechanism involves α7 nAChRs and Wnt/β-catenin pathway.

Authors:  Jie Xiang; Long-Yan Ran; Xiao-Xiao Zeng; Wen-Wen He; Yi Xu; Kun Cao; Yang-Ting Dong; Xiao-Lan Qi; Wen-Feng Yu; Yan Xiao; Zhi-Zhong Guan
Journal:  J Cell Mol Med       Date:  2021-10-28       Impact factor: 5.310

Review 3.  The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.

Authors:  Simona Di Lascio; Diego Fornasari; Roberta Benfante
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.